Literature DB >> 21969407

Antidepressants, antiplatelets and bleeding: one more thing to worry about?

David N Juurlink1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969407      PMCID: PMC3216449          DOI: 10.1503/cmaj.111576

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  14 in total

1.  Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

Authors:  F J de Abajo; L A Rodríguez; D Montero
Journal:  BMJ       Date:  1999-10-23

2.  Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.

Authors:  Christopher Labos; Kaberi Dasgupta; Hacene Nedjar; Gustavo Turecki; Elham Rahme
Journal:  CMAJ       Date:  2011-09-26       Impact factor: 8.262

3.  Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.

Authors:  Morten L Hansen; Rikke Sørensen; Mette T Clausen; Marie Louise Fog-Petersen; Jakob Raunsø; Niels Gadsbøll; Gunnar H Gislason; Fredrik Folke; Søren S Andersen; Tina K Schramm; Steen Z Abildstrøm; Henrik E Poulsen; Lars Køber; Christian Torp-Pedersen
Journal:  Arch Intern Med       Date:  2010-09-13

Review 4.  Combination warfarin-ASA therapy: which patients should receive it, which patients should not, and why?

Authors:  James D Douketis
Journal:  Thromb Res       Date:  2011-03-31       Impact factor: 3.944

5.  Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence.

Authors:  M B Lake; B Birmaher; S Wassick; K Mathos; A K Yelovich
Journal:  J Child Adolesc Psychopharmacol       Date:  2000       Impact factor: 2.576

6.  Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants.

Authors:  Welmoed E E Meijer; Eibert R Heerdink; Willem A Nolen; Ron M C Herings; Hubert G M Leufkens; Antoine C G Egberts
Journal:  Arch Intern Med       Date:  2004-11-22

7.  Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine.

Authors:  Martin A. Javors; John P. Houston; Janet L. Tekell; Stephen K. Brannan; Alan Frazer
Journal:  Int J Neuropsychopharmacol       Date:  2000-09       Impact factor: 5.176

8.  Sertraline treatment of major depression in patients with acute MI or unstable angina.

Authors:  Alexander H Glassman; Christopher M O'Connor; Robert M Califf; Karl Swedberg; Peter Schwartz; J Thomas Bigger; K Ranga Rama Krishnan; Louis T van Zyl; J Robert Swenson; Mitchell S Finkel; Charles Landau; Peter A Shapiro; Carl J Pepine; Jack Mardekian; Wilma M Harrison; David Barton; Michael Mclvor
Journal:  JAMA       Date:  2002-08-14       Impact factor: 56.272

Review 9.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

10.  Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials.

Authors:  Victor L Serebruany; Alex I Malinin; Roswith M Eisert; David C Sane
Journal:  Am J Hematol       Date:  2004-01       Impact factor: 10.047

View more
  3 in total

1.  Is third trimester serotonin reuptake inhibitor use associated with postpartum hemorrhage?

Authors:  Deborah R Kim; Emily Pinheiro; James F Luther; Heather F Eng; John L Dills; Stephen R Wisniewski; Katherine L Wisner
Journal:  J Psychiatr Res       Date:  2015-11-19       Impact factor: 4.791

2.  Antidepressants, Depression, and Venous Thromboembolism Risk: Large Prospective Study of UK Women.

Authors:  Lianne Parkin; Angela Balkwill; Siân Sweetland; Gillian K Reeves; Jane Green; Valerie Beral
Journal:  J Am Heart Assoc       Date:  2017-05-17       Impact factor: 5.501

3.  Venous Thromboembolism Risk With Antidepressants: Driven by Disease or Drugs?

Authors:  Brian R Branchford
Journal:  J Am Heart Assoc       Date:  2017-05-17       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.